Surgery Partners, Inc. (NASDAQ:SGRY) Insider Marissa Brittenham Sells 3,156 Shares

Surgery Partners, Inc. (NASDAQ:SGRY) insider Marissa Brittenham sold 3,156 shares of the stock in a transaction on Monday, March 10th. The stock was sold at an average price of $24.09, for a total value of $76,028.04. Following the completion of the sale, the insider now owns 63,408 shares in the company, valued at $1,527,498.72. This trade represents a 4.74 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Surgery Partners Stock Up 0.9 %

Surgery Partners stock traded up $0.21 during trading hours on Thursday, hitting $23.61. 819,582 shares of the stock traded hands, compared to its average volume of 1,067,027. Surgery Partners, Inc. has a one year low of $19.50 and a one year high of $33.97. The company has a market cap of $3.01 billion, a PE ratio of -49.19, a PEG ratio of 19.21 and a beta of 2.73. The firm’s 50-day moving average price is $23.48 and its two-hundred day moving average price is $26.16. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.99.

Surgery Partners (NASDAQ:SGRY) last announced its earnings results on Monday, March 3rd. The company reported $0.39 EPS for the quarter, beating analysts’ consensus estimates of $0.38 by $0.01. The firm had revenue of $864.40 million for the quarter, compared to analysts’ expectations of $828.09 million. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. On average, research analysts forecast that Surgery Partners, Inc. will post 0.67 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. FMR LLC increased its holdings in shares of Surgery Partners by 3.1% during the third quarter. FMR LLC now owns 18,311,867 shares of the company’s stock valued at $590,375,000 after acquiring an additional 546,869 shares in the last quarter. Janus Henderson Group PLC raised its holdings in Surgery Partners by 110.2% in the fourth quarter. Janus Henderson Group PLC now owns 11,554,845 shares of the company’s stock worth $244,616,000 after buying an additional 6,057,477 shares during the last quarter. Vanguard Group Inc. lifted its stake in shares of Surgery Partners by 2.3% in the fourth quarter. Vanguard Group Inc. now owns 7,618,404 shares of the company’s stock worth $161,282,000 after buying an additional 172,271 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of Surgery Partners by 18.7% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,577,861 shares of the company’s stock valued at $75,739,000 after buying an additional 563,812 shares during the last quarter. Finally, King Street Capital Management L.P. increased its position in shares of Surgery Partners by 93.1% during the fourth quarter. King Street Capital Management L.P. now owns 2,800,000 shares of the company’s stock valued at $59,276,000 after acquiring an additional 1,350,000 shares in the last quarter.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the stock. Macquarie lowered their target price on shares of Surgery Partners from $34.00 to $33.00 and set an “outperform” rating on the stock in a research note on Tuesday. JPMorgan Chase & Co. dropped their price objective on shares of Surgery Partners from $38.00 to $28.00 and set a “neutral” rating for the company in a report on Tuesday, December 3rd. Bank of America initiated coverage on Surgery Partners in a research note on Monday, December 16th. They issued a “buy” rating and a $30.00 target price on the stock. Finally, Royal Bank of Canada dropped their price target on Surgery Partners from $49.00 to $35.00 and set an “outperform” rating for the company in a research note on Wednesday, November 20th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Surgery Partners presently has an average rating of “Moderate Buy” and a consensus price target of $36.63.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.